Examination Report |
1 | TM-1 | 05 Aug 2013 |
10 | Letters related to PRAS | 28 Feb 2018 |
11 | Letters related to PRAS | 28 Feb 2018 |
12 | Journal Copy | 26 Apr 2018 |
13 | Letters related to PRAS | 09 Jul 2018 |
14 | Letters related to PRAS | 09 Jul 2018 |
15 | Certificate | 18 Jul 2018 |
16 | Affidavit | 15 Nov 2019 |
17 | TM-R(RENEWAL OF TRADE MARK) | 05 May 2023 |
2 | Reply to Exam Report (MIS-R) | 29 Nov 2015 |
3 | TM-16 | 07 Feb 2017 |
4 | Letter | 03 Mar 2017 |
5 | Letter | 08 Sep 2017 |
6 | Letter | 08 Sep 2017 |
7 | TM-M(EXTENSION OF TIME) | 19 Jan 2018 |
8 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 20 Feb 2018 |
9 | Authorization Document (POA) | 22 Feb 2018 |
1 | Hearing Notice (Show Cause) | 5592386 | 2452489 | 20 Dec 2017 |
2 | Hearing Notice (Adjourned) | 5753353 | 2579906 | 23 Jan 2018 |
3 | Tribunal Accepted Notice for : 2575857 | 5939208 | 2696632 | 22 Feb 2018 |
4 | RENEWAL INTIMATION LETTER | 15211641 | 08 May 2023 |
Febuxostat tablets febustat 80 was applied on 05 August 2013.
Trademark application was filed by ABBOTT HEALTHCARE.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Registered.
Listed application Id of Febuxostat tablets febustat 80 is 2575857.
Trademark attorney of the Febuxostat tablets febustat 80 is Zeusip.
Febuxostat tablets febustat 80 is a DEVICE as per IP India data.